We are live on ! Find out more
Sands Capital Management

Sands Capital Management Portfolio holdings

AUM $25.5B
1-Year Est. Return 26.46%
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+26.46%
3 Year Est. Return
+130.81%
5 Year Est. Return
+100.92%
10 Year Est. Return
+877.1%
AUM
$52.7B
AUM Growth
+$6.47B
Cap. Flow
-$727M
Cap. Flow %
-1.38%
Top 10 Hldgs %
43.83%
Holding
86
New
9
Increased
27
Reduced
37
Closed
10

Top Buys

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$792M
2
DASH icon
DoorDash
DASH
+$722M
3
UBER icon
Uber
UBER
+$660M
4
LRCX icon
Lam Research
LRCX
+$587M
5
TWLO icon
Twilio
TWLO
+$477M

Sector Composition

Rank Sector Weight
1 Technology 31.88%
2 Consumer Discretionary 26.32%
3 Communication Services 17.18%
4 Healthcare 14.23%
5 Financials 6.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XP icon
51
XP
XP
$8.7B
$163M 0.31%
4,111,021
+1,544,530
+60% +$63.1M
CHGG icon
52
Chegg
CHGG
$95.3M
$144M 0.27%
1,589,373
+431,515
+37% +$34.3M
HDB icon
53
HDFC Bank
HDB
$122B
$140M 0.27%
3,872,550
-77,618
-2% -$2.48M
BLUE
54
DELISTED
bluebird bio
BLUE
$137M 0.26%
244,234
-2,475
-1% -$1.57M
TXN icon
55
Texas Instruments
TXN
$256B
$115M 0.22%
701,674
+21,294
+3% +$3.31M
INDA icon
56
iShares MSCI India ETF
INDA
$6.61B
$115M 0.22%
2,850,704
+2,185,895
+329% +$79.8M
HCM icon
57
HUTCHMED
HCM
$2.04B
$113M 0.21%
3,525,958
+253,924
+8% +$7.81M
ROP icon
58
Roper Technologies
ROP
$38.9B
$108M 0.21%
250,568
+72,061
+40% +$29.6M
MRTX
59
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$86.5M 0.16%
393,886
-936,816
-70% -$203M
ONC
60
BeOne Medicines Ltd
ONC
$36.6B
$84.6M 0.16%
327,471
-139,124
-30% -$38.3M
IQV icon
61
IQVIA
IQV
$38B
$81.9M 0.16%
457,158
+88,267
+24% +$14.9M
MSFT icon
62
Microsoft
MSFT
$3.7T
$79.3M 0.15%
356,719
-3,792,990
-91% -$816M
TDG icon
63
TransDigm Group
TDG
$69.6B
$69.5M 0.13%
112,348
-31,357
-22% -$17.2M
ICE icon
64
Intercontinental Exchange
ICE
$83.4B
$67.9M 0.13%
588,988
+20,967
+4% +$2.18M
EQIX icon
65
Equinix
EQIX
$104B
$65.5M 0.12%
91,749
+2,721
+3% +$2.03M
BFAM icon
66
Bright Horizons
BFAM
$3.88B
$61.1M 0.12%
+353,377
New +$57.8M
UNH icon
67
UnitedHealth
UNH
$368B
$58.7M 0.11%
167,319
+5,956
+4% +$2M
BSX icon
68
Boston Scientific
BSX
$71.8B
$58.3M 0.11%
1,622,282
+59,571
+4% +$2.15M
DG icon
69
Dollar General
DG
$28.1B
$50M 0.1%
237,940
+8,938
+4% +$1.91M
KRTX
70
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$43.6M 0.08%
428,895
MASS icon
71
908 Devices
MASS
$347M
$22.4M 0.04%
+393,128
New +$23M
TSHA icon
72
Taysha Gene Therapies
TSHA
$1.83B
$21.8M 0.04%
820,440
SPRB
73
Spruce Biosciences
SPRB
$128M
$19.1M 0.04%
+10,493
New +$17.4M
WORK
74
DELISTED
Slack Technologies, Inc.
WORK
$15.5M 0.03%
367,019
TARS icon
75
Tarsus Pharmaceuticals
TARS
$2.82B
$10.7M 0.02%
+260,000
New +$7.41M

Similar funds

Sands Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Sands Capital Management held 86 positions worth $52.7B, up 14% from $46.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sands Capital Management's Q4 2020 filing shows 9 new, 27 increased, 37 reduced and 10 closed positions. Its largest new stake was DoorDash: 4,524,565 shares worth $646M. The largest sale was Microsoft, an estimated $816M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Sands Capital Management's largest Q4 2020 buy was DoorDash: 4,524,565 shares worth $646M.
  • Sands Capital Management added most to Mercado Libre in Q4 2020, an estimated $792M increase.
  • Sands Capital Management's biggest Q4 2020 reduction was Microsoft, cutting an estimated $816M.
  • Sands Capital Management fully exited Regeneron Pharmaceuticals in Q4 2020, selling an estimated $479M.
  • Sands Capital Management's ten largest holdings make up 44% of its $52.7B portfolio in Q4 2020.
  • Sands Capital Management opened 9 new positions and closed 10 in Q4 2020.
  • Sands Capital Management's portfolio value rose 14% quarter-over-quarter to $52.7B.

Based on Sands Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.